Literature DB >> 6861004

Specificity of hepatic aldehyde dehydrogenase inhibition by calcium carbimide (calcium cyanamide) in the rat.

C W Loomis, J F Brien.   

Abstract

Acute, oral administration of 7.0 mg/kg calcium carbimide (calcium cyanamide) to rats, 2 h before sacrifice, produced complete inhibition of hepatic, low-Km (less than 1 microM acetaldehyde) mitochondrial and cytosolic aldehyde dehydrogenase enzymes and significantly inhibited high-Km (approximately 1 mM acetaldehyde) mitochondrial, cytosolic, and microsomal aldehyde dehydrogenase isozymes. Calcium carbimide had no effect on several other hepatic enzyme activities including mitochondrial glutamate dehydrogenase and monoamine oxidase, cytosolic alcohol dehydrogenase, microsomal NADPH-cytochrome c reductase, benzo[a]pyrene hydroxylase and aminopyrine N-demethylase activities, and microsomal cytochrome P-450 content. It is concluded that calcium carbimide is a more specific inhibitor of hepatic aldehyde dehydrogenase enzymes than disulfiram.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861004     DOI: 10.1139/y83-065

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Absolute bioavailability and absorption profile of cyanamide in man.

Authors:  H Colom; J Pruñonosa; C Peraire; J Domenech; O Azcona; J Torrent; R Obach
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Changes in the inducibility of a hepatic aldehyde dehydrogenase by various effectors.

Authors:  V Vasiliou; M Marselos
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis.

Authors:  Ting Wang; Yatrik M Shah; Tsutomu Matsubara; Yueying Zhen; Tomotaka Tanabe; Tomokazu Nagano; Serge Fotso; Kristopher W Krausz; T Mark Zabriskie; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.